Francis Collins, MD, PhD, a renowned geneticist and former longtime director of the NIH announced that he has retired, leaving an agency being upended by budget cuts and layoffs. Collins -- a ...

National Institutes of Health Director Francis Collins, MD, PhD, spoke with STAT reporter Meghana Keshavan about his background and scientific interests during the Milken Institute’s Global Conference ...

After an illustrious career including 12 years as director of the National Institutes of Health (NIH) and leading the international Human Genome Project (HGP) consortium, Francis Collins, MD, PhD, ...

The question of whether to keep on Francis Collins, MD, PhD, as director of the National Institutes of Health is “under active consideration,” Newt Gingrich, former speaker of the House and current ...

WASHINGTON -- "When you mix politics and science, you just get politics." Former NIH director Francis Collins, MD, PhD, made that comment Tuesday at an event here sponsored by The Atlantic as he ...

Dr. Francis Collins has been at the forefront of the world’s most advanced biomedical research. He led the Human Genome Project and was the longest-serving director of the National Institutes of ...

In the second keynote talk in GEN’s “The State of Multiomics and NGS” virtual summit, originally broadcast on April 23, 2025, Francis Collins, MD, PhD, former Director at National Institutes of Health ...

July 9, 2009 (Staunton, Virginia) (UPDATED July 10, 2009) — People here in Francis Collins' home town had reason to be proud today, as local and national headlines announced Collins' nomination by ...

May 29, 2008 — Francis S. Collins, MD, PhD, best known for his 10-year leadership of the Human Genome Project (HGP), will step down from his position as director of the National Human Genome Research ...

Ever felt like you're just waiting for the other shoe to drop, especially regarding medical test results? Francis Collins, the former NIH director, found himself in that situation, dancing the ...

NEW YORK, Oct. 21, 2025 /PRNewswire/ -- ImmunoBrain, a clinical-stage biopharmaceutical company developing novel immunotherapies for neurodegenerative diseases, today announced the appointment of ...